The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is … or is it? (Q41556835)

3 October 2017

1 reference

title

The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is ... or is it? (English)

1 reference

3 October 2017

The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is … or is it? (English)

1 reference

Crossref

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

10 November 2024

1 reference

1 reference

cardiovascular disease

1 reference

J Meigs

1 reference

3 October 2017

D. M. Nathan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9250276

10 November 2024

J. Meigs

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9250276

10 November 2024

D. E. Singer

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9250276

10 November 2024

language of work or name

English

0 references

publication date

1 July 1997

1 reference

3 October 2017

July 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9250276

full work available at URL

10 November 2024

https://api.elsevier.com/content/article/PII:S0140673697900210?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

https://api.elsevier.com/content/article/PII:S0140673697900210?httpAccept=text/plain

10 November 2024

1 reference

Crossref

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

10 November 2024

1 reference

3 October 2017

volume

350 Suppl 1

1 reference

3 October 2017

page(s)

SI4-9

1 reference

Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr.

3 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Long-term complications of diabetes mellitus

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Heart disease and diabetes

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The World Health Organisation Multinational Study of Vascular Disease in Diabetics. Diabetes Drafting Group

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Diabetes and coronary heart disease in American Indians: The Strong Heart Study

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Diabetic myocardial infarction. Interaction of diabetes with other preinfarction risk factors

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Comparative approaches to risk reduction of coronary heart disease in Tecumseh non-insulin-dependent diabetic population.

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

NIDDM and its metabolic control predict coronary heart disease in elderly subjects

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Clustering of heart disease risk factors in diabetic compared to nondiabetic adults

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Epidemiology of diabetes mellitus in the elderly. The Framingham Study

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study.

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Coronary risk prediction in adults (the Framingham Heart Study)

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Mortality among diabetics in a national sample

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Oxidative stress and diabetic vascular complications

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Prevalence of diabetic complications in relation to risk factors

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM).

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Metabolic Control and Prevalent Cardiovascular Disease in Non-Insulin-dependent Diabetes Mellitus (NIDDM): The NIDDM Patient Outcomes Research Team

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Macrovascular complications in Mexican Americans with type II diabetes

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Family history of diabetes and cardiovascular disease risk factors and mortality among euglycemic, borderline hyperglycemic, and diabetic adults

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Long-term glycemic control relates to mortality in type II diabetes

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Development of macrovascular diseases in NIDDM patients in northern Taiwan. A 4-yr follow-up study.

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

The association of glycemia and cause-specific mortality in a diabetic population

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Is borderline fasting hyperglycemia a risk factor for cardiovascular death?

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Insulin and atheroma. 20-yr perspective

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)90021-0

10 November 2024

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9250276

10 November 2024

1 reference